Table 3. Characteristics of concurrent radiochemotherapy in cervical cancer patients (n = 43).

Details	Measurements
Radiation treatment (n/%)
External RT and BT	26/60.5
External RT + BT + lumbar aortic field (group 2)	17/39.5
Radiotherapy dose (cGy) (n/%)
External
46	1/2.3
48.6	2/4.7
50	20/46.5
50.4	17/39.5
55.8	3/7.0
External radiotherapy dose fraction (cGy) (n/%)
1.8	22/51.2
2	21/48.8
Radiotherapy energy (n/%)
External
F6Mv	23/53.5
F10Mv	10/23.3
F15Mv	10/23.3
Lumbar aortic field
F6Mv	8/47.1
F10Mv	5/29.4
F15Mv	4/23.5
Brachytherapy source (n/%)
Ir192	33/76.7
Co60	10/23.3
Total treatment time (days)
External RT, median (IQR)▵	40 (7)
External RT + BT, median (IQR)▵	58 (20)
External RT + BT + lumbar aortic field, median (IQR)▵	84 (19)
Patient with total treatment time (<63 days) (n/%)	29/67.4
Patients receiving ≥ four cycles of chemotherapy (n/%)	39/90.6

RT: radiotherapy, BT: brachytherapy,

^▵Interquartile range